TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it has received a letter from the Nasdaq Listings Qualification Department stating that EpiCept is not in compliance with the continued listing requirements of The Nasdaq Capital Market because the market value of EpiCept’s listed securities has fallen below $35,000,000 for 10 consecutive trading days (pursuant to Marketplace Rule 4310(c)(3)(B)).
